Clinicopathological and biological assessment of lung cancers with pleural dissemination

Annals of Thoracic Surgery

Volumn 69, Issue 4, 2000, Pages 1025-1029

  Ohta, Yasuhiko ^a   Tanaka, Yoko ^a   Hara, Takuo ^a   Oda, Makoto ^a   Watanabe, Shun Ichi ^a   Shimizu, Junzo ^a   Watanabe, Yoh ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOCRINE MOTILITY FACTOR; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; LUNG CANCER; MALE; PLEURA METASTASIS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

ADENOCARCINOMA; ADULT; AGED; AUTOCRINE MOTILITY FACTOR; CARCINOMA, SQUAMOUS CELL; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPHOKINES; MALE; MIDDLE AGED; PLEURA; PROGNOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034013025     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(99)01579-9     Document Type: Article

References (17)

1. Ichinose Y., Hara N., Ohta M., et al. Hypotonic cisplatin treatment for carcinomatous pleuritis found at thoracotomy. J Thorac Cardiovasc Surg. 105:1993;1041-1046.
2. Kodama K., Doi O., Higashiyama M., Yokouchi H., Tatsuta M. Long-term results of postoperative intrathoracic chemothermotherapy for lung cancer with pleural dissemination. Cancer. 72:1993;426-431.
3. Baas P., Murrer L., Zoetmulder F.A., et al. Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies. Br J Cancer. 76:1997;819-826.
4. Martini N., Bains M.S., Beattie E.J. Indications for pleurectomy in malignant effusion. Cancer. 35:1975;734-738.
5. Reshad K., Inui K., Takeuchi Y., et al. Treatment of malignant pleural effusion. Chest. 88:1985;393-397.
6. Webb W.R., Ozmen V., Moulder P.V., et al. Iodized talc pleurodesis for the treatment of pleural effusions. J Thorac Cardiovasc Surg. 103:1992;881-886.
7. Shimizu J., Oda M., Morita K., et al. Comparison of pleuropneumonectomy and limited surgery for lung cancer with pleural dissemination. J Surg Oncol. 61:1996;1-6.
8. Rusch V.W., Albain K.S., Crowley J.J., et al. Neoadjuvant therapy a novel and effective treatment for stage IIIb nonsmall cell lung cancer . Ann Thorac Surg. 58:1994;290-295.
9. Sobin L.H., Wittekind C. TNM classification of malignant tumours. 1997;Wiley-Liss, New York.
10. Albain K.S., Rusch V.W., Crowley J.J., et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small cell lung cancer mature results of southwest oncology group phase II study 8805 . J Clin Oncol. 13:1995;1880-1892.
11. Senger D.R., Galli S.J., Dvorak A.M., Perruzzi C.A., Harvey V.S., Dvorak H.F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 219:1983;983-985.
12. Ohta Y., Watanabe Y., Murakami S., et al. Vascular endothelial growth factor and lymph node metastasis in primary lung cancer. Br J Cancer. 76:1997;1041-1045.
13. Ohta Y., Tomita Y., Oda M., Watanabe S., Murakami S., Watanabe Y. Tumor angiogenesis and recurrence in stage I nonsmall cell lung cancer. Ann Thorac Surg. 67:1999;1034-1038.
14. Ohta Y., Endo Y., Tanaka M., et al. Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer. Clin Cancer Res. 2:1996;1411-1416.
15. Liotta L.A., Mandler R., Murano G., et al. Tumor cell autocrine motility factor. Proc Natl Acad Sci USA. 83:1986;3302-3306.
16. Watanabe H., Carmi P., Hogan V., et al. Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor. J Biol Chem. 266:1991;13442-13448.
17. Taniguchi K., Yonemura Y., Nojima N., et al. The relation between the growth patterns of gastric carcinoma and the expression of hepatocyte growth factor receptor (c-met), autocrine motility factor receptor, and urokinase-type plasminogen activator receptor. Cancer. 82:1998;2112-2122.